KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects
Oral Diseases · 2025
DOI: 10.1111/odi.15401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Jiahao Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Peri-Implantitis, Porphyromonas gingivalis, Anti-Bacterial Agents, Antimicrobial Peptides. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program.
Abstract (Originalsprache)
Aims
Peri‐implantitis is a common dental complication characterized by inflammation of peri‐implant tissues and progressive bone loss. With the rise of antibiotic resistance, this study investigates the potential of antimicrobial peptides (AMPs), specifically KL‐12, a novel peptide derived from cecropin B, as an alternative therapeutic strategy against Porphyromonas gingivalis , a key pathogen in peri‐implantitis.
Methods
We evaluated the structural stability, antibacterial efficacy, and cytotoxicity of KL‐12. Antibacterial activity was measured against P. gingivalis , while the peptide's mode of action was explored concerning its effect on the gingipain proteases essential for the bacterium's nutrient acquisition. Additionally, we assessed KL‐12's impact on macrophage polarization and anti‐inflammatory responses.
Results
The findings revealed that KL‐12 exhibited significant antibacterial activity against P. gingivalis and demonstrated potential as a specific inhibitor of gingipains. It was observed that KL‐12 disrupts bacterial viability through mechanisms involving deformation and nutrient deprivation, rather than traditional pore formation. KL‐12 effectively modulated macrophage polarization, promoting M2 differentiation and enhancing anti‐inflammatory responses.
Conclusion
These results suggest that KL‐12 functions as a dual‐action therapeutic agent, targeting both bacterial pathogens and inflammatory processes in the management of peri‐implantitis. Future studies will aim to clarify the molecular mechanisms underlying KL‐12's antibacterial and immunomodulatory effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China.
- School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
ORCID-Profile: Jiahao Qin
Förderung
- National College Students Innovation and Entrepreneurship Training Program
Zitieren
APA
Qin, J., Yang, S., Meng, W., Zhou, Z., Yu, Z., & Zhang, X. (2025). KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects. Oral Diseases. https://doi.org/10.1111/odi.15401
Vancouver
Qin J, Yang S, Meng W, Zhou Z, Yu Z, Zhang X. KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects. Oral Diseases. 2025. doi:10.1111/odi.15401
BibTeX
@article{Qin2025,
author = {Qin, Jiahao and Yang, Shuwei and Meng, Weixu and Zhou, Zanxun and Yu, Zihui and Zhang, Xi},
title = {KL‐12 Peptide Targets Peri‐Implantitis via Dual Antibacterial and Immunomodulatory Effects},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15401}
}
EUVIMED